Camp4 Therapeutics Corp (CAMP)

May 16, 2025, 6:00 AM EDT - 21 days ago

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

May 13, 2025, 4:05 PM EDT - 23 days ago

CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights

Apr 28, 2025, 4:30 PM EDT - 5 weeks ago

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

Apr 10, 2025, 6:56 AM EDT - 2 months ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2

EWTX GNFT

Mar 27, 2025, 4:05 PM EDT - 2 months ago

CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 18, 2025, 8:00 AM EDT - 2 months ago

CAMP4 Appoints Multiple Industry Veterans to its Board of Directors

Mar 13, 2025, 10:39 PM EDT - 3 months ago

CORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Mar 13, 2025, 2:58 PM EDT - 3 months ago

CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025

Feb 6, 2025, 8:00 AM EST - 4 months ago

CAMP4 to Participate in Upcoming Investor Conferences

Jan 7, 2025, 4:05 PM EST - 5 months ago

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

Dec 2, 2024, 8:00 AM EST - 6 months ago

CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 21, 2024, 4:05 PM EST - 7 months ago

CAMP4 Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 3:06 PM EST - 7 months ago

CAMP4 Analyst Highlights Rare Disease Platform Potential

Oct 10, 2024, 7:07 PM EDT - 8 months ago

CAMP4 Announces Pricing of Initial Public Offering

Oct 1, 2024, 4:30 PM EDT - 8 months ago

Camp4 Therapeutics Targets IPO On Early Positive Results

Sep 20, 2024, 3:35 PM EDT - 9 months ago

Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO

Sep 20, 2024, 2:23 PM EDT - 9 months ago

Kaiser Permanente-backed biopharma CAMP4 files for US IPO

Sep 20, 2024, 1:35 PM EDT - 9 months ago

CAMP4 Therapeutics IPO Registration Document (S-1)

Sep 17, 2024, 8:00 AM EDT - 9 months ago

CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders